MedPath
NMPA Approval

Maralixibat Chloride Oral Solution

国药准字HJ20230061

May 29, 2023

Drug Information

氯马昔巴特口服溶液

迈芮倍

口服溶液剂

30ml:285mg(按C₄₀H₅₆N₃O₄S计)

化学药品

May 29, 2023

May 28, 2028

Company Information

Applicant Company

989 E Hillsdale, Suite 300 Foster City, CA 94404 United States of America

Manufacturing Company

17800 Lapointe Street, Mirabel, Quebec J7J0W8 CANADA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氯马昔巴特口服溶液 - NMPA 批准文号 | MedPath